Ignite Creation Date:
2025-12-24 @ 7:08 PM
Ignite Modification Date:
2026-02-21 @ 9:25 PM
Study NCT ID:
NCT07022457
Status:
RECRUITING
Last Update Posted:
2025-08-03
First Post:
2025-05-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
UK ENcorafenib and BInimetinib Real-world Study in Melanoma
Sponsor:
Pierre Fabre Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
5126-10-2024
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |